Last Updated: 02/24/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Rapid Intracranial Response With Tarlatamab in Patients With Untreated Brain Metastases From SCLC-A Real-World Case Series: Case Report.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: January 25, 2025
Impact of select actionable genomic alterations on efficacy of neoadjuvant immunotherapy in resectable non-small cell lung cancer.
Journal: Journal for immunotherapy of cancer
Published: September 21, 2024
Mutational Characteristics and Clinical Outcomes for Lung Adenocarcinoma With EGFR Germline Mutations.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: March 18, 2024
Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial.
Journal: Lancet (London, England)
Published: June 20, 2023
Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 17, 2023
Integration of Remote Symptom and Biometric Monitoring Into the Care of Adult Patients With Cancer Receiving Chemotherapy-A Decentralized Feasibility Pilot Study.
Journal: JCO oncology practice
Published: February 23, 2023
Brief Report: Clinical Response, Toxicity, and Resistance Mechanisms to Osimertinib Plus MET Inhibitors in Patients With EGFR-Mutant MET-Amplified NSCLC.
Journal: JTO clinical and research reports
Published: January 26, 2023
Safety, tolerability, and clinical activity of selinexor in combination with pembrolizumab in treatment of metastatic non-small cell lung cancer.
Journal: Cancer
Published: September 30, 2022
Final efficacy outcomes of atezolizumab with chemoradiation for unresectable NSCLC: The phase II DETERRED trial.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 22, 2022
Effect of dexamethasone on dyspnoea in patients with cancer (ABCD): a parallel-group, double-blind, randomised, controlled trial.
Journal: The Lancet. Oncology
Published: May 23, 2022
Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial.
Journal: Nature medicine
Published: May 14, 2022
Last Updated: 02/24/2026